Wu Du

2.5k citations

37 papers · 1.9k indexed · h-index 19

Impact in

Toxicology top 1%
- Bioactive Compounds and Antitumor Agents
Organic Chemistry top 2%
- Catalytic C–H Functionalization Methods
- Asymmetric Synthesis and Catalysis

Papers in ⓘ

Toxicology 6
- Bioactive Compounds and Antitumor Agents 5
Organic Chemistry 16
- Catalytic C–H Functionalization Methods 6
- Synthetic Organic Chemistry Methods 3
- Radical Photochemical Reactions 3

Co-authors: Dennis P. Curran (14 shared papers)Dale L. Boger (5 shared papers)Inkyu Hwang (4 shared papers)Benjamin F. Cravatt (3 shared papers)Donmienne Leung (3 shared papers)Heng Cheng (3 shared papers)Christophe Hardouin (3 shared papers)Shuji Masumoto (2 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Medicinal Chemistry (4 papers)Bioorganic & Medicinal Chemistry (3 papers)Cancer Research (3 papers)Journal of the American Chemical Society (2 papers)
Partner nations: United States China Japan

In The Last Decade

Wu Du

35 papers receiving 1.9k citations

Peers

Countries citing papers authored by Wu Du

Since Specialization

Citations

This map shows the geographic impact of Wu Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wu Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wu Du more than expected).

Fields of papers citing papers by Wu Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wu Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wu Du. The network helps show where Wu Du may publish in the future.

Co-authors

The 25 scholars most cited alongside Wu Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wu Du Line = papers co-authored together Wu Du links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Self-renewal as a therapeutic target in human colorectal cancer Nature Medicine ·Antonija Kreso, Peter van Galen, Nicholas Pedley, Evelyne Lima‐Fernandes, Catherine Frelin, Thomas W. Davis, Liangxian Cao, Ramil Baiazitov, Wu Du, Nadiya Sydorenko, Young‐Choon Moon, Lianne Gibson, Yadong Wang, Cherry Leung, Norman N. Iscove, C.H. Arrowsmith, Eva Szentgyörgyi, Steven Gallinger, John E. Dick, Catherine O′Brien	2013	378
2	Switching Enantiofacial Selectivities Using One Chiral Source: Catalytic Enantioselective Synthesis of the Key Intermediate for (20S)-Camptothecin Family by (S)-Selective Cyanosilylation of Ketones Journal of the American Chemical Society ·Kazuo Yabu, Shuji Masumoto, Shingo Yamasaki, Yoshitaka Hamashima, Motomu Kanai, Wu Du, Dennis P. Curran, Masakatsu Shibasaki	2001	196
3	Discovery of a Potent, Selective, and Efficacious Class of Reversible α-Ketoheterocycle Inhibitors of Fatty Acid Amide Hydrolase Effective as Analgesics Journal of Medicinal Chemistry ·Dale L. Boger, Hiroshi Miyauchi, Wu Du, Christophe Hardouin, Robert Fecik, Heng Cheng, Inkyu Hwang, Michael P. Hedrick, Donmienne Leung, Orlando Acevedo, Cristiano R. W. Guimarães, William L. Jorgensen, Benjamin F. Cravatt	2004	187
4	Towards new anticancer drugs: a decade of advances in synthesis of camptothecins and related alkaloids Tetrahedron ·Wu Du	2003	164
5	The Novel Silatecan 7-tert-Butyldimethylsilyl-10-hydroxycamptothecin Displays High Lipophilicity, Improved Human Blood Stability, and Potent Anticancer Activity Journal of Medicinal Chemistry ·David Bom, Dennis P. Curran, Stefan Kruszewski, Stephen G. Zimmer, J. Thompson Strode, Glenda Kohlhagen, Wu Du, Ashok J. Chavan, Kimberly A. Fraley, Alex L. Bingcang, Lori J. Latus, Yves Pommier, Thomas G. Burke	2000	133
6	Synthesis of Carbocyclic and Heterocyclic Fused Quinolines by Cascade Radical Annulations of UnsaturatedN-Aryl Thiocarbamates, Thioamides, and Thioureas Organic Letters ·Wu Du, Dennis P. Curran	2003	95
7	Discovery of an exceptionally potent and selective class of fatty acid amide hydrolase inhibitors enlisting proteome-wide selectivity screening: concurrent optimization of enzyme inhibitor potency and selectivity Bioorganic & Medicinal Chemistry Letters ·Donmienne Leung, Wu Du, Christophe Hardouin, Heng Cheng, Inkyu Hwang, Benjamin F. Cravatt, Dale L. Boger	2005	93
8	Palladium-Promoted Cascade Reactions of Isonitriles and 6-Iodo-N-propargylpyridones: Synthesis of Mappicines, Camptothecins, and Homocamptothecins Organic Letters ·Dennis P. Curran, Wu Du	2002	88
9	Development of selective mono or dual PROTAC degrader probe of CDK isoforms European Journal of Medicinal Chemistry ·Fei Zhou, Luyu Chen, Chao-Guo Cao, Jiang Yu, Xiaojiao Luo, Peiting Zhou, Lifeng Zhao, Wu Du, Jijun Cheng, Yongmei Xie, Yuanwei Chen	2019	85
10	Potent and Selective α-Ketoheterocycle-Based Inhibitors of the Anandamide and Oleamide Catabolizing Enzyme, Fatty Acid Amide Hydrolase Journal of Medicinal Chemistry ·F. Anthony Romero, Wu Du, Inkyu Hwang, Thomas J. Rayl, F. Scott Kimball, Donmienne Leung, Heather Hoover, Richard L. Apodaca, J. Guy Breitenbucher, Benjamin F. Cravatt, Dale L. Boger	2007	67
11	Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers Journal of Medicinal Chemistry ·Chao-Guo Cao, Jie Yang, Yong Chen, (unknown), Peiting Zhou, Yingwei Wang, Wu Du, Lifeng Zhao, Yuanwei Chen	2020	65
12	Complement activation associated with polysorbate 80 in beagle dogs International Immunopharmacology ·Shidong Qiu, Zhaohua Liu, Li Hou, Yuanyuan Li, Jiao Wang, Hong Wang, Wu Du, Wenfang Wang, Yizhuo Qin, Zhaoping Liu	2012	50
13	A Versatile Prodrug Approach for Liposomal Core-Loading of Water-Insoluble Camptothecin Anticancer Drugs Journal of the American Chemical Society ·Xinli Liu, Bert C. Lynn, Jun Zhang, Lin Song, David Bom, Wu Du, Dennis P. Curran, Thomas G. Burke	2002	40
14	Semisynthesis of DB-67 and other silatecans from camptothecin by thiol-promoted addition of silyl radicals Bioorganic & Medicinal Chemistry ·Wu Du	2003	36
15	Asymmetric total synthesis of (20R)-homocamptothecin, substituted homocamptothecins and homosilatecans Tetrahedron ·Ana E. Gabarda, Wu Du, Thomas Isarno, Raghuram S. Tangirala, Dennis P. Curran	2002	29
16	Heterocyclic sulfoxide and sulfone inhibitors of fatty acid amide hydrolase Bioorganic & Medicinal Chemistry Letters ·Wu Du, Christophe Hardouin, Heng Cheng, Inkyu Hwang, Dale L. Boger	2004	28
17	Synthesis and evaluation of a novel E-ring modified α-hydroxy keto ether analogue of camptothecin Bioorganic & Medicinal Chemistry ·Wu Du, Dennis P. Curran, Robert L. Bevins, Stephen G. Zimmer, Jun Zhang, Thomas G. Burke	2002	24
18	Catalytic Enantioselective Synthesis of (20S)-Camptothecin Intermediates Using Cyanosilylation of Ketones Promoted by D-Glucose-derived Lanthanide Catalyst Heterocycles ·Masakatsu Shibasaki, Kazuo Yabu, Shuji Masumoto, Motomu Kanai, Wu Du, Dennis P. Curran	2003	21
19	A one-pot synthesis of 3-substituted-5-carbonylmethyl-1,2,4-oxadiazoles from β-keto esters and amidoximes under solvent-free conditions Tetrahedron Letters ·Wu Du, Quang Truong, Hongbo Qi, Yan Guo, Harry R. Chobanian, William K. Hagmann, Jeffrey J. Hale	2007	18
20	Analysis of human topoisomerase I inhibition and interaction with the cleavage site +1 deoxyguanosine, via in vitro experiments and molecular modeling studies Bioorganic & Medicinal Chemistry ·Gary S. Laco, Wu Du, Glenda Kohlhagen, Jane M. Sayer, Donald M. Jerina, Thomas G. Burke, Dennis P. Curran, Yves Pommier	2004	17

About Wu Du

Wu Du is a scholar working on Toxicology, Organic Chemistry, Pharmacology, Oncology and Pharmaceutical Science, having authored 37 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (11 papers), Protein Degradation and Inhibitors (6 papers), Catalytic C–H Functionalization Methods (6 papers), Bioactive Compounds and Antitumor Agents (5 papers), Cannabis and Cannabinoid Research (5 papers), Synthetic Organic Chemistry Methods (3 papers), Radical Photochemical Reactions (3 papers) and Neutropenia and Cancer Infections (3 papers). The work is most often cited by research in Toxicology (175 citations), Organic Chemistry (786 citations), Pharmacology (330 citations), Oncology (448 citations) and Molecular Biology (957 citations). Wu Du has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Dennis P. Curran, Dale L. Boger, Inkyu Hwang, Benjamin F. Cravatt, Donmienne Leung, Heng Cheng, Christophe Hardouin, Shuji Masumoto, Masakatsu Shibasaki and Motomu Kanai. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Cancer Research and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact